Literature DB >> 14730115

Opposite effects of clozapine and sulpiride on the lipopolysaccharide-induced inhibition of the GR-mediated gene transcription in fibroblast cells.

Agnieszka Basta-Kaim1, Bogusława Budziszewska, Lucylla Jaworska-Feil, Monika Leśkiewicz, Magdalena Tetich, Marta Kubera, Simon Scharpe, Władysław Lasoń.   

Abstract

Previously, we have found that some antipsychotic drugs are able to inhibit glucocorticoid receptor (GR)-mediated gene transcription. Since these drugs are known not only to inhibit hypothalamic-pituitary-adrenal (HPA) axis activity, but also to modulate the immunological system, the aim of the present study was to compare the effect of sulpiride and clozapine on GR function under basal culture conditions and during activation by lipopolysaccharide (LPS). The effect of clozapine and sulpiride alone and with LPS, the immune system activator, on glucocorticoid-mediated gene transcription was investigated in fibroblast cells, stably transfected with a mouse mammary tumor virus--chloramphenicol acetyltransferase plasmid (LMCAT cells). Treatment of the cells with clozapine (3-10 microM) for 2 days significantly and in concentration-dependent manner decreased the chloramphenicol acetyltransferase (CAT) activity, while sulpiride (1, 3, 5 and 10 microM) was without any effect. LPS (1 microg/ml) given alone inhibited the corticosterone-induced gene transcription by ca. 35%. Clozapine (3, 5 and 10 microM) inhibited the effect of LPS (1 microM), while sulpiride, which alone had no effect on GR function, enhanced LPS (1 microM) action. The obtained results indicate that inhibition of GR-mediated gene transcription by LPS and clozapine can be a mechanism by which these compounds blocked some effects induced by glucocorticoids. Opposite effect of clozapine and sulpiride on LPS action may result from their distinct effect on activity of some kinases involved in regulation of GR transcriptional function and may determine their utility in the treatment of schizophrenia with or without immune system activation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14730115

Source DB:  PubMed          Journal:  Pol J Pharmacol        ISSN: 1230-6002


  4 in total

1.  Increased Expression of Brain-Derived Neurotrophic Factor Transcripts I and VI, cAMP Response Element Binding, and Glucocorticoid Receptor in the Cortex of Patients with Temporal Lobe Epilepsy.

Authors:  G A Martínez-Levy; L Rocha; F Rodríguez-Pineda; M A Alonso-Vanegas; A Nani; R M Buentello-García; M Briones-Velasco; D San-Juan; J Cienfuegos; C S Cruz-Fuentes
Journal:  Mol Neurobiol       Date:  2017-05-19       Impact factor: 5.590

Review 2.  Risk factors for development of depression and psychosis. Glucocorticoid receptors and pituitary implications for treatment with antidepressant and glucocorticoids.

Authors:  Carmine M Pariante
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

Review 3.  The glucocorticoid receptor: a revisited target for toxins.

Authors:  Jeanette I Webster Marketon; Esther M Sternberg
Journal:  Toxins (Basel)       Date:  2010-06-09       Impact factor: 4.546

Review 4.  Psychotropic Drug Effects on Steroid Stress Hormone Release and Possible Mechanisms Involved.

Authors:  Zuzana Romanova; Natasa Hlavacova; Daniela Jezova
Journal:  Int J Mol Sci       Date:  2022-01-14       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.